nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprazinone—Tenderness—Estramustine—prostate cancer	0.0253	0.0262	CcSEcCtD
Eprazinone—Tenderness—Estrone—prostate cancer	0.0242	0.025	CcSEcCtD
Eprazinone—Abscess—Degarelix—prostate cancer	0.0221	0.0229	CcSEcCtD
Eprazinone—Tenderness—Estradiol valerate/Dienogest—prostate cancer	0.0211	0.0218	CcSEcCtD
Eprazinone—Ulcer—Flutamide—prostate cancer	0.0206	0.0213	CcSEcCtD
Eprazinone—Venous thrombosis—Conjugated Estrogens—prostate cancer	0.018	0.0187	CcSEcCtD
Eprazinone—Tenderness—Bicalutamide—prostate cancer	0.0162	0.0168	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Estramustine—prostate cancer	0.016	0.0166	CcSEcCtD
Eprazinone—Fluid overload—Conjugated Estrogens—prostate cancer	0.0157	0.0162	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Nilutamide—prostate cancer	0.0142	0.0147	CcSEcCtD
Eprazinone—Abdominal discomfort—Estramustine—prostate cancer	0.0133	0.0137	CcSEcCtD
Eprazinone—Necrosis—Conjugated Estrogens—prostate cancer	0.0124	0.0128	CcSEcCtD
Eprazinone—Abscess—Conjugated Estrogens—prostate cancer	0.0123	0.0127	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Cabazitaxel—prostate cancer	0.012	0.0124	CcSEcCtD
Eprazinone—Extravasation—Goserelin—prostate cancer	0.0113	0.0117	CcSEcCtD
Eprazinone—Tenderness—Goserelin—prostate cancer	0.0113	0.0117	CcSEcCtD
Eprazinone—Cyclizine—SULT1E1—prostate cancer	0.0112	0.326	CrCbGaD
Eprazinone—Extravasation—Conjugated Estrogens—prostate cancer	0.0112	0.0116	CcSEcCtD
Eprazinone—Tenderness—Conjugated Estrogens—prostate cancer	0.0112	0.0116	CcSEcCtD
Eprazinone—Abdominal discomfort—Degarelix—prostate cancer	0.0105	0.0109	CcSEcCtD
Eprazinone—Ulcer—Goserelin—prostate cancer	0.0104	0.0108	CcSEcCtD
Eprazinone—Ulcer—Conjugated Estrogens—prostate cancer	0.0103	0.0107	CcSEcCtD
Eprazinone—Flatulence—Estramustine—prostate cancer	0.0095	0.00984	CcSEcCtD
Eprazinone—Necrosis—Mitoxantrone—prostate cancer	0.00925	0.00958	CcSEcCtD
Eprazinone—Flatulence—Estrone—prostate cancer	0.00908	0.0094	CcSEcCtD
Eprazinone—Venous thrombosis—Capecitabine—prostate cancer	0.009	0.00933	CcSEcCtD
Eprazinone—Tenderness—Estradiol—prostate cancer	0.00893	0.00925	CcSEcCtD
Eprazinone—Extravasation—Mitoxantrone—prostate cancer	0.00832	0.00862	CcSEcCtD
Eprazinone—Ulcer—Estradiol—prostate cancer	0.00824	0.00853	CcSEcCtD
Eprazinone—Phlebitis—Conjugated Estrogens—prostate cancer	0.0082	0.0085	CcSEcCtD
Eprazinone—Flatulence—Estradiol valerate/Dienogest—prostate cancer	0.00792	0.00821	CcSEcCtD
Eprazinone—Necrosis—Etoposide—prostate cancer	0.0077	0.00797	CcSEcCtD
Eprazinone—Ulcer—Mitoxantrone—prostate cancer	0.00768	0.00795	CcSEcCtD
Eprazinone—Infection—Abiraterone—prostate cancer	0.0076	0.00787	CcSEcCtD
Eprazinone—Hyperkalaemia—Mitoxantrone—prostate cancer	0.00713	0.00739	CcSEcCtD
Eprazinone—Extravasation—Etoposide—prostate cancer	0.00692	0.00717	CcSEcCtD
Eprazinone—Phlebitis—Estradiol—prostate cancer	0.00657	0.0068	CcSEcCtD
Eprazinone—Necrosis—Docetaxel—prostate cancer	0.0064	0.00662	CcSEcCtD
Eprazinone—Ulcer—Etoposide—prostate cancer	0.00639	0.00661	CcSEcCtD
Eprazinone—Venous thrombosis—Epirubicin—prostate cancer	0.00627	0.0065	CcSEcCtD
Eprazinone—Phlebitis—Mitoxantrone—prostate cancer	0.00612	0.00634	CcSEcCtD
Eprazinone—Flatulence—Bicalutamide—prostate cancer	0.00609	0.0063	CcSEcCtD
Eprazinone—Body temperature increased—Abiraterone—prostate cancer	0.00604	0.00626	CcSEcCtD
Eprazinone—Abdominal discomfort—Conjugated Estrogens—prostate cancer	0.00586	0.00607	CcSEcCtD
Eprazinone—Infection—Cabazitaxel—prostate cancer	0.00584	0.00605	CcSEcCtD
Eprazinone—Venous thrombosis—Doxorubicin—prostate cancer	0.0058	0.00601	CcSEcCtD
Eprazinone—Extravasation—Docetaxel—prostate cancer	0.00575	0.00596	CcSEcCtD
Eprazinone—Body temperature increased—Nilutamide—prostate cancer	0.00552	0.00572	CcSEcCtD
Eprazinone—Necrosis—Prednisone—prostate cancer	0.00552	0.00571	CcSEcCtD
Eprazinone—Abscess—Prednisone—prostate cancer	0.00547	0.00567	CcSEcCtD
Eprazinone—Diarrhoea—Estramustine—prostate cancer	0.00539	0.00558	CcSEcCtD
Eprazinone—Hyponatraemia—Mitoxantrone—prostate cancer	0.00529	0.00548	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Mitoxantrone—prostate cancer	0.00527	0.00546	CcSEcCtD
Eprazinone—Diarrhoea—Abiraterone—prostate cancer	0.00523	0.00542	CcSEcCtD
Eprazinone—Ulcer—Capecitabine—prostate cancer	0.00514	0.00532	CcSEcCtD
Eprazinone—Phlebitis—Etoposide—prostate cancer	0.00509	0.00527	CcSEcCtD
Eprazinone—Infection—Bicalutamide—prostate cancer	0.00501	0.00519	CcSEcCtD
Eprazinone—Vomiting—Estramustine—prostate cancer	0.005	0.00518	CcSEcCtD
Eprazinone—Rash—Estramustine—prostate cancer	0.00496	0.00514	CcSEcCtD
Eprazinone—Dermatitis—Estramustine—prostate cancer	0.00496	0.00514	CcSEcCtD
Eprazinone—Body temperature increased—Degarelix—prostate cancer	0.00493	0.00511	CcSEcCtD
Eprazinone—Vomiting—Abiraterone—prostate cancer	0.00486	0.00503	CcSEcCtD
Eprazinone—Rash—Abiraterone—prostate cancer	0.00482	0.00499	CcSEcCtD
Eprazinone—Dermatitis—Abiraterone—prostate cancer	0.00482	0.00499	CcSEcCtD
Eprazinone—Vomiting—Estrone—prostate cancer	0.00478	0.00495	CcSEcCtD
Eprazinone—Diarrhoea—Nilutamide—prostate cancer	0.00478	0.00495	CcSEcCtD
Eprazinone—Diarrhoea—Flutamide—prostate cancer	0.00476	0.00493	CcSEcCtD
Eprazinone—Rash—Estrone—prostate cancer	0.00474	0.00491	CcSEcCtD
Eprazinone—Dermatitis—Estrone—prostate cancer	0.00474	0.00491	CcSEcCtD
Eprazinone—Abdominal discomfort—Estradiol—prostate cancer	0.00469	0.00485	CcSEcCtD
Eprazinone—Nausea—Estramustine—prostate cancer	0.00468	0.00484	CcSEcCtD
Eprazinone—Body temperature increased—Cabazitaxel—prostate cancer	0.00465	0.00481	CcSEcCtD
Eprazinone—Ulcer—Prednisone—prostate cancer	0.00458	0.00474	CcSEcCtD
Eprazinone—Nausea—Estrone—prostate cancer	0.00447	0.00463	CcSEcCtD
Eprazinone—Vomiting—Nilutamide—prostate cancer	0.00444	0.0046	CcSEcCtD
Eprazinone—Vomiting—Flutamide—prostate cancer	0.00442	0.00458	CcSEcCtD
Eprazinone—Rash—Nilutamide—prostate cancer	0.0044	0.00456	CcSEcCtD
Eprazinone—Dermatitis—Nilutamide—prostate cancer	0.0044	0.00456	CcSEcCtD
Eprazinone—Rash—Flutamide—prostate cancer	0.00438	0.00454	CcSEcCtD
Eprazinone—Dermatitis—Flutamide—prostate cancer	0.00438	0.00454	CcSEcCtD
Eprazinone—Necrosis—Epirubicin—prostate cancer	0.00431	0.00447	CcSEcCtD
Eprazinone—Abscess—Epirubicin—prostate cancer	0.00428	0.00443	CcSEcCtD
Eprazinone—Diarrhoea—Degarelix—prostate cancer	0.00427	0.00442	CcSEcCtD
Eprazinone—Flatulence—Goserelin—prostate cancer	0.00423	0.00439	CcSEcCtD
Eprazinone—Infection—Ethinyl Estradiol—prostate cancer	0.00423	0.00438	CcSEcCtD
Eprazinone—Phlebitis—Docetaxel—prostate cancer	0.00423	0.00438	CcSEcCtD
Eprazinone—Flatulence—Conjugated Estrogens—prostate cancer	0.00419	0.00434	CcSEcCtD
Eprazinone—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00417	0.00432	CcSEcCtD
Eprazinone—Nausea—Nilutamide—prostate cancer	0.00415	0.0043	CcSEcCtD
Eprazinone—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00414	0.00429	CcSEcCtD
Eprazinone—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00413	0.00428	CcSEcCtD
Eprazinone—Nausea—Flutamide—prostate cancer	0.00413	0.00428	CcSEcCtD
Eprazinone—Phlebitis—Capecitabine—prostate cancer	0.0041	0.00424	CcSEcCtD
Eprazinone—Diarrhoea—Cabazitaxel—prostate cancer	0.00402	0.00416	CcSEcCtD
Eprazinone—Necrosis—Doxorubicin—prostate cancer	0.00399	0.00413	CcSEcCtD
Eprazinone—Body temperature increased—Bicalutamide—prostate cancer	0.00399	0.00413	CcSEcCtD
Eprazinone—Vomiting—Degarelix—prostate cancer	0.00397	0.00411	CcSEcCtD
Eprazinone—Abscess—Doxorubicin—prostate cancer	0.00396	0.0041	CcSEcCtD
Eprazinone—Rash—Degarelix—prostate cancer	0.00393	0.00407	CcSEcCtD
Eprazinone—Dermatitis—Degarelix—prostate cancer	0.00393	0.00407	CcSEcCtD
Eprazinone—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.0039	0.00404	CcSEcCtD
Eprazinone—Extravasation—Epirubicin—prostate cancer	0.00388	0.00402	CcSEcCtD
Eprazinone—Vomiting—Cabazitaxel—prostate cancer	0.00374	0.00387	CcSEcCtD
Eprazinone—Nausea—Degarelix—prostate cancer	0.00371	0.00384	CcSEcCtD
Eprazinone—Hyponatraemia—Docetaxel—prostate cancer	0.00366	0.00379	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	0.00364	0.00377	CcSEcCtD
Eprazinone—Extravasation—Doxorubicin—prostate cancer	0.00359	0.00372	CcSEcCtD
Eprazinone—Ulcer—Epirubicin—prostate cancer	0.00358	0.00371	CcSEcCtD
Eprazinone—Hyponatraemia—Capecitabine—prostate cancer	0.00354	0.00367	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	0.00353	0.00365	CcSEcCtD
Eprazinone—Nausea—Cabazitaxel—prostate cancer	0.00349	0.00362	CcSEcCtD
Eprazinone—Infection—Goserelin—prostate cancer	0.00348	0.00361	CcSEcCtD
Eprazinone—Infection—Conjugated Estrogens—prostate cancer	0.00345	0.00357	CcSEcCtD
Eprazinone—Diarrhoea—Bicalutamide—prostate cancer	0.00345	0.00357	CcSEcCtD
Eprazinone—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00337	0.00349	CcSEcCtD
Eprazinone—Flatulence—Estradiol—prostate cancer	0.00336	0.00348	CcSEcCtD
Eprazinone—Hyperkalaemia—Epirubicin—prostate cancer	0.00333	0.00345	CcSEcCtD
Eprazinone—Ulcer—Doxorubicin—prostate cancer	0.00331	0.00343	CcSEcCtD
Eprazinone—Vomiting—Bicalutamide—prostate cancer	0.00321	0.00332	CcSEcCtD
Eprazinone—Rash—Bicalutamide—prostate cancer	0.00318	0.00329	CcSEcCtD
Eprazinone—Dermatitis—Bicalutamide—prostate cancer	0.00318	0.00329	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.00314	0.00325	CcSEcCtD
Eprazinone—Hyperkalaemia—Doxorubicin—prostate cancer	0.00308	0.00319	CcSEcCtD
Eprazinone—Nausea—Bicalutamide—prostate cancer	0.00299	0.0031	CcSEcCtD
Eprazinone—Abdominal discomfort—Capecitabine—prostate cancer	0.00292	0.00303	CcSEcCtD
Eprazinone—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00292	0.00302	CcSEcCtD
Eprazinone—Phlebitis—Epirubicin—prostate cancer	0.00285	0.00295	CcSEcCtD
Eprazinone—Body temperature increased—Goserelin—prostate cancer	0.00277	0.00287	CcSEcCtD
Eprazinone—Infection—Estradiol—prostate cancer	0.00276	0.00286	CcSEcCtD
Eprazinone—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00275	0.00284	CcSEcCtD
Eprazinone—Vomiting—Ethinyl Estradiol—prostate cancer	0.00271	0.00281	CcSEcCtD
Eprazinone—Rash—Ethinyl Estradiol—prostate cancer	0.00269	0.00278	CcSEcCtD
Eprazinone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00268	0.00278	CcSEcCtD
Eprazinone—Phlebitis—Doxorubicin—prostate cancer	0.00264	0.00273	CcSEcCtD
Eprazinone—Infection—Mitoxantrone—prostate cancer	0.00257	0.00267	CcSEcCtD
Eprazinone—Nausea—Ethinyl Estradiol—prostate cancer	0.00253	0.00262	CcSEcCtD
Eprazinone—Hyponatraemia—Epirubicin—prostate cancer	0.00247	0.00256	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.00246	0.00255	CcSEcCtD
Eprazinone—Diarrhoea—Goserelin—prostate cancer	0.0024	0.00249	CcSEcCtD
Eprazinone—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00238	0.00246	CcSEcCtD
Eprazinone—Hyponatraemia—Doxorubicin—prostate cancer	0.00228	0.00236	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.00227	0.00236	CcSEcCtD
Eprazinone—Vomiting—Goserelin—prostate cancer	0.00223	0.00231	CcSEcCtD
Eprazinone—Rash—Goserelin—prostate cancer	0.00221	0.00229	CcSEcCtD
Eprazinone—Dermatitis—Goserelin—prostate cancer	0.00221	0.00229	CcSEcCtD
Eprazinone—Vomiting—Conjugated Estrogens—prostate cancer	0.00221	0.00229	CcSEcCtD
Eprazinone—Body temperature increased—Estradiol—prostate cancer	0.0022	0.00228	CcSEcCtD
Eprazinone—Rash—Conjugated Estrogens—prostate cancer	0.00219	0.00227	CcSEcCtD
Eprazinone—Dermatitis—Conjugated Estrogens—prostate cancer	0.00219	0.00227	CcSEcCtD
Eprazinone—Infection—Etoposide—prostate cancer	0.00214	0.00222	CcSEcCtD
Eprazinone—Flatulence—Capecitabine—prostate cancer	0.00209	0.00217	CcSEcCtD
Eprazinone—Nausea—Goserelin—prostate cancer	0.00208	0.00216	CcSEcCtD
Eprazinone—Nausea—Conjugated Estrogens—prostate cancer	0.00206	0.00214	CcSEcCtD
Eprazinone—Body temperature increased—Mitoxantrone—prostate cancer	0.00205	0.00212	CcSEcCtD
Eprazinone—Diarrhoea—Estradiol—prostate cancer	0.0019	0.00197	CcSEcCtD
Eprazinone—Infection—Docetaxel—prostate cancer	0.00178	0.00184	CcSEcCtD
Eprazinone—Diarrhoea—Mitoxantrone—prostate cancer	0.00177	0.00184	CcSEcCtD
Eprazinone—Vomiting—Estradiol—prostate cancer	0.00177	0.00183	CcSEcCtD
Eprazinone—Rash—Estradiol—prostate cancer	0.00175	0.00182	CcSEcCtD
Eprazinone—Dermatitis—Estradiol—prostate cancer	0.00175	0.00181	CcSEcCtD
Eprazinone—Infection—Capecitabine—prostate cancer	0.00172	0.00178	CcSEcCtD
Eprazinone—Body temperature increased—Etoposide—prostate cancer	0.0017	0.00176	CcSEcCtD
Eprazinone—Nausea—Estradiol—prostate cancer	0.00165	0.00171	CcSEcCtD
Eprazinone—Vomiting—Mitoxantrone—prostate cancer	0.00165	0.00171	CcSEcCtD
Eprazinone—Rash—Mitoxantrone—prostate cancer	0.00163	0.00169	CcSEcCtD
Eprazinone—Dermatitis—Mitoxantrone—prostate cancer	0.00163	0.00169	CcSEcCtD
Eprazinone—Levomethadyl Acetate—CYP3A5—prostate cancer	0.00157	0.0457	CrCbGaD
Eprazinone—Nausea—Mitoxantrone—prostate cancer	0.00154	0.00159	CcSEcCtD
Eprazinone—Infection—Prednisone—prostate cancer	0.00153	0.00159	CcSEcCtD
Eprazinone—Diarrhoea—Etoposide—prostate cancer	0.00147	0.00153	CcSEcCtD
Eprazinone—Flatulence—Epirubicin—prostate cancer	0.00146	0.00151	CcSEcCtD
Eprazinone—Diphenhydramine—CYP2C18—prostate cancer	0.00145	0.0421	CrCbGaD
Eprazinone—Levomethadyl Acetate—CYP19A1—prostate cancer	0.00145	0.0421	CrCbGaD
Eprazinone—Body temperature increased—Docetaxel—prostate cancer	0.00142	0.00147	CcSEcCtD
Eprazinone—Methadone—CYP2C18—prostate cancer	0.0014	0.0407	CrCbGaD
Eprazinone—Modafinil—CYP3A5—prostate cancer	0.00138	0.04	CrCbGaD
Eprazinone—Body temperature increased—Capecitabine—prostate cancer	0.00137	0.00142	CcSEcCtD
Eprazinone—Vomiting—Etoposide—prostate cancer	0.00137	0.00142	CcSEcCtD
Eprazinone—Rash—Etoposide—prostate cancer	0.00136	0.00141	CcSEcCtD
Eprazinone—Dermatitis—Etoposide—prostate cancer	0.00136	0.00141	CcSEcCtD
Eprazinone—Flatulence—Doxorubicin—prostate cancer	0.00135	0.0014	CcSEcCtD
Eprazinone—Fentanyl—CYP3A5—prostate cancer	0.00135	0.0391	CrCbGaD
Eprazinone—Ranolazine—CYP3A4—prostate cancer	0.0013	0.0377	CrCbGaD
Eprazinone—Cinnarizine—CYP2A6—prostate cancer	0.00129	0.0374	CrCbGaD
Eprazinone—Nausea—Etoposide—prostate cancer	0.00128	0.00133	CcSEcCtD
Eprazinone—Benzatropine—CYP2C19—prostate cancer	0.00127	0.0367	CrCbGaD
Eprazinone—Diarrhoea—Docetaxel—prostate cancer	0.00123	0.00127	CcSEcCtD
Eprazinone—Body temperature increased—Prednisone—prostate cancer	0.00122	0.00126	CcSEcCtD
Eprazinone—Infection—Epirubicin—prostate cancer	0.0012	0.00124	CcSEcCtD
Eprazinone—Diarrhoea—Capecitabine—prostate cancer	0.00119	0.00123	CcSEcCtD
Eprazinone—Diphenhydramine—SLC22A1—prostate cancer	0.00118	0.0344	CrCbGaD
Eprazinone—Vomiting—Docetaxel—prostate cancer	0.00114	0.00118	CcSEcCtD
Eprazinone—Rash—Docetaxel—prostate cancer	0.00113	0.00117	CcSEcCtD
Eprazinone—Dermatitis—Docetaxel—prostate cancer	0.00113	0.00117	CcSEcCtD
Eprazinone—Infection—Doxorubicin—prostate cancer	0.00111	0.00115	CcSEcCtD
Eprazinone—Vomiting—Capecitabine—prostate cancer	0.0011	0.00114	CcSEcCtD
Eprazinone—Rash—Capecitabine—prostate cancer	0.00109	0.00113	CcSEcCtD
Eprazinone—Dermatitis—Capecitabine—prostate cancer	0.00109	0.00113	CcSEcCtD
Eprazinone—Nausea—Docetaxel—prostate cancer	0.00106	0.0011	CcSEcCtD
Eprazinone—Diarrhoea—Prednisone—prostate cancer	0.00106	0.00109	CcSEcCtD
Eprazinone—Nausea—Capecitabine—prostate cancer	0.00103	0.00107	CcSEcCtD
Eprazinone—Vomiting—Prednisone—prostate cancer	0.000982	0.00102	CcSEcCtD
Eprazinone—Rash—Prednisone—prostate cancer	0.000974	0.00101	CcSEcCtD
Eprazinone—Dermatitis—Prednisone—prostate cancer	0.000973	0.00101	CcSEcCtD
Eprazinone—Body temperature increased—Epirubicin—prostate cancer	0.000955	0.000989	CcSEcCtD
Eprazinone—Modafinil—CYP2C19—prostate cancer	0.000937	0.0272	CrCbGaD
Eprazinone—Methadone—CYP3A5—prostate cancer	0.000923	0.0268	CrCbGaD
Eprazinone—Nausea—Prednisone—prostate cancer	0.000917	0.00095	CcSEcCtD
Eprazinone—Cinnarizine—CYP1A1—prostate cancer	0.000903	0.0262	CrCbGaD
Eprazinone—Body temperature increased—Doxorubicin—prostate cancer	0.000884	0.000915	CcSEcCtD
Eprazinone—Methadone—CYP19A1—prostate cancer	0.000851	0.0247	CrCbGaD
Eprazinone—Diarrhoea—Epirubicin—prostate cancer	0.000827	0.000856	CcSEcCtD
Eprazinone—Atomoxetine—CYP2C19—prostate cancer	0.000806	0.0234	CrCbGaD
Eprazinone—Vomiting—Epirubicin—prostate cancer	0.000768	0.000795	CcSEcCtD
Eprazinone—Diarrhoea—Doxorubicin—prostate cancer	0.000765	0.000792	CcSEcCtD
Eprazinone—Rash—Epirubicin—prostate cancer	0.000762	0.000789	CcSEcCtD
Eprazinone—Dermatitis—Epirubicin—prostate cancer	0.000761	0.000788	CcSEcCtD
Eprazinone—Nausea—Epirubicin—prostate cancer	0.000718	0.000743	CcSEcCtD
Eprazinone—Vomiting—Doxorubicin—prostate cancer	0.000711	0.000736	CcSEcCtD
Eprazinone—Rash—Doxorubicin—prostate cancer	0.000705	0.00073	CcSEcCtD
Eprazinone—Dermatitis—Doxorubicin—prostate cancer	0.000704	0.000729	CcSEcCtD
Eprazinone—Levomethadyl Acetate—CYP3A4—prostate cancer	0.000681	0.0198	CrCbGaD
Eprazinone—Nausea—Doxorubicin—prostate cancer	0.000664	0.000688	CcSEcCtD
Eprazinone—Diphenhydramine—CYP2C19—prostate cancer	0.000651	0.0189	CrCbGaD
Eprazinone—Methadone—CYP2C19—prostate cancer	0.000628	0.0182	CrCbGaD
Eprazinone—Modafinil—CYP3A4—prostate cancer	0.000596	0.0173	CrCbGaD
Eprazinone—Dextropropoxyphene—CYP3A4—prostate cancer	0.000589	0.0171	CrCbGaD
Eprazinone—Fentanyl—CYP3A4—prostate cancer	0.000582	0.0169	CrCbGaD
Eprazinone—Benzphetamine—CYP3A4—prostate cancer	0.000516	0.015	CrCbGaD
Eprazinone—Atomoxetine—CYP3A4—prostate cancer	0.000512	0.0149	CrCbGaD
Eprazinone—Methadone—CYP3A4—prostate cancer	0.000399	0.0116	CrCbGaD
